Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11352
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Norman, Trevor R | en |
dc.contributor.author | Burrows, Graham D | en |
dc.contributor.author | McIntyre, I M | en |
dc.date.accessioned | 2015-05-16T00:56:32Z | |
dc.date.available | 2015-05-16T00:56:32Z | |
dc.date.issued | 1990-04-01 | en |
dc.identifier.citation | International Clinical Psychopharmacology; 5(2): 111-7 | en |
dc.identifier.govdoc | 2199575 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/11352 | en |
dc.description.abstract | Six healthy volunteers participated in a study of the pharmacokinetic and psychomotor effects of a single dose of 2 mg of alprazolam compared to placebo when given at night. Alprazolam reached a maximum concentration in the plasma between 0.5 and 2.5 h after the dose. It was extensively distributed to the tissues as shown by the large apparent volume of distribution (1.42 l/kg) and slowly eliminated (t1/2 = 13.7 h). Significant impairment of choice reaction time occurred 1 and 11 h after the dose of alprazolam compared to placebo. Critical flicker fusion was also impaired after alprazolam but the difference from the placebo administration did not reach significance. | en |
dc.language.iso | en | en |
dc.subject.other | Administration, Oral | en |
dc.subject.other | Adult | en |
dc.subject.other | Alprazolam.administration & dosage.pharmacokinetics | en |
dc.subject.other | Arousal.drug effects | en |
dc.subject.other | Double-Blind Method | en |
dc.subject.other | Drug Administration Schedule | en |
dc.subject.other | Female | en |
dc.subject.other | Flicker Fusion.drug effects | en |
dc.subject.other | Humans | en |
dc.subject.other | Male | en |
dc.subject.other | Randomized Controlled Trials as Topic | en |
dc.subject.other | Sensory Thresholds.drug effects | en |
dc.title | Pharmacokinetic and pharmacodynamic effects of a single nocturnal dose of alprazolam. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | International clinical psychopharmacology | en |
dc.identifier.affiliation | Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia | en |
dc.description.pages | 111-7 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/2199575 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Norman, Trevor R | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Psychiatry (University of Melbourne) | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.